Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a publicly traded the market company. As of May 21, 2026, LMRI trades at $7.40 with a market cap of $650.47M and a P/E ratio of 362.75. LMRI moved +5.71% today. Year to date, LMRI is -56.03%; over the trailing twelve months it is flat. Its 52-week range spans $6.45 to $19.45. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces LMRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes LMRI SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $7.40 |
| Market Cap | $650.47M |
| P/E Ratio | 362.75 |
| EPS | $0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.45 |
| 52-Week Low | $6.45 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $252.54M |
| Net Income | $1.72M |
| Gross Margin | 0.00% |
4 analysts cover LMRI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.